Literature DB >> 8726363

Reduction-oxidation (redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells.

S C Tyagi1, S Kumar, S Borders.   

Abstract

Latent matrix metalloproteinases (MMPs) in normal myocardium are activated in end-stage heart failure. In vitro oxidized glutathione (GSSG) activates myocardial MMPs which contains a cysteine residue. In vivo GSSG induce the collagen lysis and cardiac dilatation. To assess whether thiol and non-thiol reducing agents have direct effect on the interstitial human heart fibroblast (HHF) proliferation and MMP expression, HHF and polyoma virus transformed fibroblast cells were cultured with or without the thiol-containing reduced (GSH) or oxidized (GSSG) glutathiones, pyrrolidine dithiocarbamate (PDTC) and N-acetylcysteine (NAC), and non-thiol ascorbic acid. After 100 micrograms/ml (approximately 0.3 mM) GSH or PDTC treatment the proliferative (synthetic) phenotype of transformed fibroblast cells was changed to quiescent (contractile) phenotype. Also, after GSH, PDTC, and ascorbic acid treatment the medium was then analyzed for MMP activity by zymography. The results indicate reduction in MMP expression in transformed fibroblast cells after GSH and PDTC treatments and no effect after ascorbic acid treatment. Based on reverse zymography, we observed the level of tissue inhibitor of metalloproteinase (TIMP) at a decreased level in transformed cells. The effect of the reducing agent at the gene transcription was measured by estimating mRNA (Northern blot analysis) of MMP and of TIMP in the cells that were cultured in medium in the presence and absence of GSH. These results indicate that GSH induces MMP-2 and MMP-1 expression in normal HHF and that GSH reduces MMP-2 and MMP-1 in transformed fibroblast cells. After the treatment, the TIMP-2 level was repressed in normal HHF and TIMP-2 level increased in transformed fibroblast cells. These events are dependent on the nuclear transcription factor activity on the collagenase promoter in normal HHF cells. On the other hand, in polyoma transform fibroblast cells these events are not dependent on this collagenase promoter. These results suggest that oxidative environment induces normal HHF cell proliferation, and the reducing agent decreases normal HHF cell proliferation by inducing MMP and repressing TIMP gene transcription. In transformed cells reducing agents inhibit MMP expression and increase TIMP levels, which suggests a role of antioxidants in preventing tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726363     DOI: 10.1002/(sici)1097-4644(19960401)61:1<139::aid-jcb15>3.0.co;2-j

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Andrea Callegari; Yuhua Liu; Collin C White; Alan Chait; Peter Gough; Elaine W Raines; David Cox; Terrance J Kavanagh; Michael E Rosenfeld
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 2.  Redox-control of matrix metalloproteinase-1: a critical link between free radicals, matrix remodeling and degenerative disease.

Authors:  Supriya Kar; Sita Subbaram; Pauline M Carrico; J Andrés Melendez
Journal:  Respir Physiol Neurobiol       Date:  2010-09-08       Impact factor: 1.931

Review 3.  Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium.

Authors:  Deborah A Siwik; Wilson S Colucci
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

4.  Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats.

Authors:  M R Ebrahimkhani; S Kiani; F Oakley; T Kendall; A Shariftabrizi; S M Tavangar; L Moezi; S Payabvash; A Karoon; H Hoseininik; D A Mann; K P Moore; A R Mani; A R Dehpour
Journal:  Gut       Date:  2006-03-16       Impact factor: 23.059

Review 5.  Matrix metalloproteinase in left ventricular remodeling and heart failure.

Authors:  Suresh Shastry; Melvin R Hayden; Pamela A Lucchesi; Suresh C Tyagi
Journal:  Curr Cardiol Rep       Date:  2003-05       Impact factor: 2.931

6.  Expression of the recessive glomerulosclerosis gene Mpv17 regulates MMP-2 expression in fibroblasts, the kidney, and the inner ear of mice.

Authors:  A Reuter; A Nestl; R M Zwacka; J Tuckermann; R Waldherr; E M Wagner; M Höyhtyä; A M Meyer zum Gottesberge; P Angel; H Weiher
Journal:  Mol Biol Cell       Date:  1998-07       Impact factor: 4.138

Review 7.  The myocardial matrix and the development and progression of ventricular remodeling.

Authors:  J D Sackner-Bernstein
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 3.955

8.  Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model.

Authors:  Massih Bahar; Shahnaz Khaghani; Parvin Pasalar; Maliheh Paknejad; Mohammad Reza Khorramizadeh; Hossein Mirmiranpour; Siavash Gerayesh Nejad
Journal:  Nutr J       Date:  2010-11-30       Impact factor: 3.271

9.  The Axonal Motor Neuropathy-Related HINT1 Protein Is a Zinc- and Calmodulin-Regulated Cysteine SUMO Protease.

Authors:  Elsa Cortés-Montero; María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Javier Garzón
Journal:  Antioxid Redox Signal       Date:  2019-06-24       Impact factor: 8.401

Review 10.  Lung extracellular matrix and redox regulation.

Authors:  Walter H Watson; Jeffrey D Ritzenthaler; Jesse Roman
Journal:  Redox Biol       Date:  2016-02-18       Impact factor: 11.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.